Galmed Pharmaceuticals
GLMD
GLMD
25 hedge funds and large institutions have $804K invested in Galmed Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
53% less capital invested
Capital invested by funds: $1.7M → $804K (-$896K)
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$7K | |
| 2 | +$6.19K | |
| 3 | +$6.01K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$6K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$4.45K |
Top Sellers
| 1 | -$13.3K | |
| 2 | -$3K | |
| 3 | -$1.91K | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$1.83K |
| 5 |
Millennium Management
New York
|
-$1.27K |